Antibodies reacting with carbohydrate epitopes on neural glycoconjugates are present in several forms of neuropathy. These include monoclonal antibodies to the myelin-associated glycoprotein (MAG) and to gan gliosides in patients with neuropathy in association with IgM gammopathy, as well as polyclonal antibodies to gangliosides in inflammatory polyneuropathies, such as Guillain-Barré syndrome and multifocal motor neuropathy. There are several correlations between antibody specificity and clinical symptoms, including anti-MAG antibodies with demyelinating sensory or sensorimotor neuropathy, anti-GM1 ganglioside anti bodies with motor nerve disorders, anti-GQ1b ganglioside antibodies with Miller-Fisher syndrome, and antibodies to gangliosides containing disialosyl moieties with sensory ataxic neuropathy. This review will emphasize recent developments concerning the origins of the anti-glycoconjugate antibodies in patients, pathogenic mechanisms by which the antibodies may cause the neuropathies, and the implications of these findings for therapy. NEUROSCIENTIST 3:195-204, 1997
Posner JBAnti-Hu autoantibody associated sensory neuropathy/ encephalomyelitis: a model of paraneoplastic syndrome. Perspect Biol Med1995,38:167-181.
2.
Dalakas MC, Quarles RHAutoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens ? Ann Neurol1996;39:419-422.
3.
Svennerholm L. , Asbury A., Reisfeld R., et al. Biological function of gangliosides . Prog Brain Res1994;101
4.
Jungalwala FBExpression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system—a reviewNeurochem Res1994;19:945-957.
5.
Quarles R., Colman D., Salzer J., Trapp B.Myelin-associated glycoprotem. In: Martenson R, editor. Myelin: biology and chemistry. Boca Raton, FLCRC Press1992;4413-4448
6.
Fruttiger M. , Montag D., Schachner M., Martini R.Crucial role for the myelin-associated glycoprotem in the maintenance of axon-myelin integrityEur J Neurosci1995;7:511-515.
7.
Quarles RHHuman monoclonal antibodies associated with neuropathy. Methods Enzymol1989;179:291-299.
8.
Marcus DM, Latov N., Hsi BP, Gillard BKMeasurement and significance of antibodies against GM1 ganglioside . Report of a workshop, 18 Apnl 1989, Chicago, IL, U.S.A. J Neuroimmunol 1989 ;25:255-259
9.
Daune GC, Farrer RG, Dalakas MC, Quarles RHSensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside . Ann Neurol1992;31:683-685.
10.
Thomas P., Willison H.Paraproteinaemic neuropathy. Bailleres Clin Neurol1994;3:129-147.
11.
Latov N.Pathogenesis and therapy of neuropathies associated with monclonal gammopathies . Ann Neurol1995;37(Suppl):S32-S42
12.
Ilyas AA, Chou DK, Jungalwala FB, Costello C., Quarles RHVariability in the structural requirements for binding of human monoclonal anti-myelin-associated glycoprotein immunoglobulin M antibodies and HNK-1 to sphingoglycolipid antigens. J Neurochem1990;55:594-601.
13.
Kornberg A. , Pestronk A.Chronic motor neuropathies diagnosis, therapy and pathogenesis. Ann Neurol1995;37(Suppl):S43-S50.
14.
van der Meché Fvd, van Doom PVGuillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies . Ann Neurol1995; 37(Suppl):S14-S31.
15.
Quarles RH, Dalakas MCDo anti-ganglioside antibodies cause human peripheral neuropathies ? J Clin Invest1996;97:1136-1137.
16.
Latov N.Antibodies to glycoconjugates in neuropathy and motor neuron disease . Prog Brain Res1994;101:295-303.
17.
Ayadi H., Mihaesco E., Congy N., et al. H chain V region sequences of three human monoclonal IgM with anti-myelin-associated glycoprotem activity. J Immunol1992;148:2812-2816.
18.
Weng NP, Yu-Lee LY, Sanz I., Patten BM, Marcus DMStructure and specificities of anti-ganglioside autoantibodies associated with motor neuropathies. J Immunol1992,149:2518-2529.
19.
Lee G., Ware RR, Latov N.Somatically mutated member of the human V lambda VIII gene family encodes anti-myelin-associated glycoprotein (MAG) activity. J Neuroimmunol1994;51:45-52.
20.
Paterson G. , Wilson G., Kennedy PG, Willison HJAnalysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation. J Immunol1995;155:3049-3059.
21.
Willison HJ , O'Hanlon GM, Paterson G., et al A somatically mutated human antiganglioside IgM antibody that induces expenmental neuropathy in mice is encoded by the vanable region heavy chain gene, V1-18. J Clin Invest1996;97:1155-1164.
22.
Jacobs B., Doom Pv, Schmitz P., et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome. Ann Neurol1996;40:181-187.
23.
Ho TW, Mishu B., Li CY, et al. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain1995;118:597-605.
24.
Yuki N., Taki T., Inagaki F., et al. A bacterium lipopolysacchande that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure. J Exp Med1993;178:1771-1775.
25.
Aspmall GO, McDonald AG, Pang H., Kurjanczyk LA, Penner JLLipopolysacchandes of Campylobacter jejuni serotype O:19: structures of core oligosacchande regions from the serostram and two bacterial isolates from patients with the Guillain-Barre syndrome. Biochemistry1994;33:241-249.
26.
Yuki N., Taki T., Takahashi M., et al. Molecular mimicry between GQ1b ganglioside and hpopolysacchandes of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol1994;36.791-793.
27.
Salloway S. , Mermel LA, Seamans M., et al Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3Infect Immun1996;64.2945-2949
28.
Latov N., Wirguin I., Suturkova-Milosevic L., Bnam C.Mechanism of induction of anti-ganglioside antibodies in immune mediated neuropathy [abstract]. J Neurochem1996;66:S97C.
29.
Mendell JR, Sahenk Z., Whitaker JN, et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotem antibody. Ann Neurol1985; 17:243-254.
30.
Hammer JA, O'Shannessy DJ, De Leon M., et al. Immunoreactivity of PMP-22, P0, and other 19 to 28 kDa glycoprotems m peripheral nerve myelin of mammals and fish with HNK1 and related antibodies . J Neurosci Res1993,35546-558.
Kohnyama T. , Kusunoki S., Anga T., et al. Subcellular localization of sulfated glucuromc acid-containing glycolipids reacting with anti-myelin-associated glycoprotein antibody. J Neurochem1987; 48:1516-1522.
33.
Kanda T., Yoshino H., Anga T., Yamawaki M., Yu RKGlycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy. J Cell Biol1994; 126:235-246.
34.
Hays AP, Latov N., Takatsu M., Sherman WHExperimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protem. Neurology1987 ;37:242-256.
35.
Willison HJ , Trapp BD, Bacher JD, et al Demyelination induced by mtraneural injection of human antimyelin-associated glycoprotein antibodies. Muscle Nerve1988;111169-1176.
36.
Kahn SN, Stanton NL, Sumner AJ, et al. Analysis of the feline immune response to human myelin-associated glycoprotein. J Neurol Sci1989;89:141-148.
37.
O'Shannessy DJ, Willison HJ, Inuzuka T., Dobersen MJ, Quarles RHThe species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies. J Neuroimmunol1985;9:255-268.
38.
Yamawaki M. , Vasquez A., Younes AB, et al. Sensitization of Lewis rats with sulfoglucuronyl paragloboside: electrophysiological and immunological studies of an animal model of peripheral neuropathy. J Neurosci Res1996,44:58-65.
39.
Tatum AHExperimental paraprotem neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotem. Ann Neurol1993;33:502-506.
40.
Ogawa-Goto K., Ohta Y., Kubota K., et al Glycosphingolipids of human peripheral nervous system myelins isolated from cauda equma. J Neurochem1993;61:1398-1403
41.
Svennerholm L., Bostrom K., Fredman P., et al Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochim Biophys Acta1994;1214:115-123.
42.
Corbo M., Quattrini A., Lugaresi A., et al. Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann Neurol1992;32:487-493.
43.
Corbo M., Quattnm A., Latov N., Hays APLocalization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology1993;43:809-814.
44.
Thomas FP, Adapon PH, Goldberg GP, Latov N., Hays APLocalization of neural epitopes that bind to IgM monoclonal autoantibodies (M-protems) from two patients with motor neuron disease. J Neuroimmunol1989;21:31-39.
45.
Gnffin JW, Li CY, Ho TW, et al. Guillain-Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain1995;118:577-595.
46.
Thomas FP, Trojaborg W., Nagy C., et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol (Berl) 1991; 82:378-383.
47.
Santoro M., Uncim A., Corbo M., et al. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol1992;31:385-390.
48.
Heiman-Patterson T., Krupa T., Thompson P., et al. Anti-GM1/ GD1b M-proteins damage human spinal cord neurons co-cultured with muscle. J Neurol Sci1993;120:38-45.
49.
Roberts M., Willison HJ, Vincent A., Newsom-Davis J.Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol1995;38:111-118.
50.
Kusunoki S., Chiba A., Tai T., Kanazawa I.Localization of GM1 and GD1b antigens in the human peripheral nervous system . Muscle Nerve1993;16:752-756.
51.
Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I.Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia m Miller-Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies . Neurology1993;43:1911-1917.
52.
Ilyas AA, Quarles RH, Dalakas MC, Fishman PH, Brady ROMonoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann Neurol1985 ;18:655-659.
53.
Ohsawa T., Miyatake T., Yuki N.Anti-B-senes ganglioside-recognizing autoantibodies in an acute sensory neuropathy patient cause cell death of rat dorsal root ganglion neurons. Neurosci Lett1993;157:167-170.
54.
Kusunoki S. , Shimizu J., Chiba A., et al. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol1996;39:424-431.
55.
Roberts M., Willison H., Vincent A., Newsom-Davis J.Serum factor in Miller-Fisher variant of Guillain-Barre syndrome and neurotransmitter releaseLancet1994;343:454-455.
56.
Dyck PJ, Low PA, Windebank AJ, et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med1991;325:1482-1486.
57.
Dalakas M., Quarles R., Farrer R., et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy. Ann Neurol1996;40:792-795.
58.
Dalakas M.Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: Present and future prospects. Ann Neurol1995 ;37(Suppl 1):S2-S13.
